Webb R - Search Results

1

Renin inhibition with aliskiren: where are we now, and where are we going?

Azizi M, Webb R, Nussberger J, Hollenberg NK. Azizi M, et al. Among authors: webb r. J Hypertens. 2006 Feb;24(2):243-56. doi: 10.1097/01.hjh.0000202812.72341.99. J Hypertens. 2006. PMID: 16508564 Review.

2

Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.

Pu Q, Brassard P, Javeshghani DM, Iglarz M, Webb RL, Amiri F, Schiffrin EL. Pu Q, et al. J Hypertens. 2008 Feb;26(2):322-33. doi: 10.1097/HJH.0b013e3282f16aaf. J Hypertens. 2008. PMID: 18192847

3

Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.

Awad AS, Webb RL, Carey RM, Siragy HM. Awad AS, et al. J Hypertens. 2004 Aug;22(8):1571-7. doi: 10.1097/01.hjh.0000133718.86451.6a. J Hypertens. 2004. PMID: 15257181

4

Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.

Siragy HM, El-Kersh MA, De Gasparo M, Webb RL, Carey RM. Siragy HM, et al. J Hypertens. 2002 Jun;20(6):1157-63. doi: 10.1097/00004872-200206000-00028. J Hypertens. 2002. PMID: 12023686

5

Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.

Awad AS, Webb RL, Carey RM, Siragy HM. Awad AS, et al. Am J Hypertens. 2005 Apr;18(4 Pt 1):544-8. doi: 10.1016/j.amjhyper.2004.10.018. Am J Hypertens. 2005. PMID: 15831366

6

Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.

Dechend R, Shagdarsuren E, Gratze P, Fiebeler A, Pilz B, Meiners S, Derer W, Feldman DL, Webb R, Muller DN. Dechend R, et al. Among authors: webb r. J Renin Angiotensin Aldosterone Syst. 2007 Jun;8(2):81-4. doi: 10.3317/jraas.2007.008. J Renin Angiotensin Aldosterone Syst. 2007. PMID: 17703434 Free article.

7

Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study.

Huo Y, Li W, Webb R, Zhao L, Wang Q, Guo W. Huo Y, et al. Among authors: webb r. J Clin Hypertens (Greenwich). 2019 Jan;21(1):67-76. doi: 10.1111/jch.13437. Epub 2018 Dec 11. J Clin Hypertens (Greenwich). 2019. PMID: 30536595 Free PMC article. Clinical Trial.

8

A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model.

Hallow KM, Lo A, Beh J, Rodrigo M, Ermakov S, Friedman S, de Leon H, Sarkar A, Xiong Y, Sarangapani R, Schmidt H, Webb R, Kondic AG. Hallow KM, et al. Among authors: webb r. Am J Physiol Regul Integr Comp Physiol. 2014 May;306(9):R647-62. doi: 10.1152/ajpregu.00039.2013. Epub 2014 Feb 5. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 24500431 Free article.

9

Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.

Wang BH, von Lueder TG, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H. Wang BH, et al. Among authors: webb r. Int J Cardiol. 2015;186:104-5. doi: 10.1016/j.ijcard.2015.03.116. Epub 2015 Mar 11. Int J Cardiol. 2015. PMID: 25828104 No abstract available.

10

Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.

Siragy HM, Xue C, Webb RL. Siragy HM, et al. J Cardiovasc Pharmacol. 2006 May;47(5):636-42. doi: 10.1097/01.fjc.0000211750.01326.b3. J Cardiovasc Pharmacol. 2006. PMID: 16775501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,504 results

Search Page

Filters